{"id":"https://openalex.org/A5159568389","orcid":null,"observed_orcids":[],"display_name":"I LASSOULI","raw_author_names":["I LASSOULI"],"full_name":"I LASSOULI","works_count":1,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5159568389","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210138534","ror":"https://ror.org/03sbc8x80","display_name":"Centre Hospitalier Universitaire Ibn Rochd","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I4210138534","ror":"https://ror.org/03sbc8x80","display_name":"Centre Hospitalier Universitaire Ibn Rochd","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]}],"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":1,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","value":4.2e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":3.9e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","value":3e-06,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","score":0.34040001034736633},{"id":"2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","score":0.3109000027179718},{"id":"2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","score":0.3012999892234802},{"id":"2779912601","wikidata":"https://www.wikidata.org/wiki/Q1621830","display_name":"Lupus nephritis","score":0.24040000140666962},{"id":"2778674544","wikidata":"https://www.wikidata.org/wiki/Q1414805","display_name":"Systemic disease","score":0.211899995803833}],"counts_by_year":[{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["I LASSOULI"],"block_key":"i lassouli","works_api_url":"https://api.openalex.org/works?filter=author.id:A5159568389","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2026-10-26T00:00:00"}
